Could a Once-Daily probiotic help bones? new trial begins

NCT ID NCT07538167

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a new once-daily version of a probiotic food (SBD111) works as well as the current twice-daily version in healthy adults aged 35 and older. The goal is to see if the new formula leads to similar levels of helpful gut microbes. Participants take capsules for 28 days and provide stool samples at home.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
SBD111 (probiotic bacteria, yeast, and prebiotic fibers)
What this could lead to
If successful, this could lead to a more convenient once-daily probiotic food for managing bone loss after menopause.
What could go wrong
This is an early-stage trial focused on gut microbe levels, not bone health directly. The new formula may not work as well as the current one, and results may not apply to people with osteoporosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MENOPAUSE RELATED CONDITIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Bone Diseases, Metabolic osteoporosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.